The oncogenic BCR/ABL tyrosine kinase induces constitutive DNA damage in Philadelphia chromosome (Ph 1 )-positive leukemia cells. We find that BCR/ABL-induced reactive oxygen species (ROS) cause chronic oxidative DNA damage resulting in double-strand breaks (DSBs) in S and G2/M cell cycle phases. These lesions are repaired by BCR/ABL-stimulated homologous recombination repair (HRR) and non-homologous end-joining (NHEJ) mechanisms. A high mutation rate is detected in HRR products in BCR/ABL-positive cells, but not in the normal counterparts. In addition, large deletions are found in NHEJ products exclusively in BCR/ABL cells. We propose that the following series of events may contribute to genomic instability of Ph 1
INTRODUCTION
The bcr/abl chimeric gene is derived from relocation of part of the c-abl gene from chromosome 9 to part of the bcr gene locus on chromosome 22 [t(9;22) , Philadelphia chromosome=Ph 1 ], and is present in most chronic myelogenous leukemia (CML) and a cohort of acute lymphocytic leukemia (ALL) patients 1, 2 . BCR/ABL exhibits two complementary roles in cancer: stimulation of signaling pathways that render leukemia cells independent of their environment and modulation of the response to DNA damage causing drug resistance 3, 4 . In contrast to normal cells, BCR/ABL-positive cells seem to be better equipped to survive genotoxic damage due to their enhanced ability to repair DNA lesions, prolonged activation of the G2/M checkpoint to provide more time for repair, and inhibited pro-apoptotic mechanisms 5 . Clinical observations and experimental findings have shown that BCR/ABL stimulates also genomic instability, leading to mutations and chromosomal abnormalities [6] [7] [8] [9] [10] [11] [12] . The accumulation of genetic errors is believed to be responsible for the transition from a relatively benign CML chronic phase (CML-CP) to the aggressive blast crisis phase (CML-BC). Aberrations in pathways regulating the DNA damage response in BCR/ABL-positive leukemia cells may contribute to this phenomenon.
DNA damage can directly result from genotoxic treatment or may simply occur as a consequence of the infidelity of genome duplication and/or genotoxic effects of compounds such as reactive oxygen species (ROS). ROS are generated as a normal byproduct of normal oxidative metabolism in eukaryotic cells and can cause damage to all molecules, including DNA 13 . Singlestrand oxidative DNA damage, including species such as 8-oxoguanine (8-oxoG) , has been documented for many years 14 . If not repaired, the damage can induce a number of deleterious effects including mutations 15 and double-strand breaks (DSBs) 16 leading to an elevated cancer risk 17 .
BCR/ABL kinase-stimulated ROS 18 may exert a chronic genotoxic stress causing DNA damage in leukemia cells. Given the fact that mechanisms necessary for the repair of DNA For personal use only. on August 31, 2017 . by guest www.bloodjournal.org From lesions might be altered by BCR/ABL 10, [19] [20] [21] [22] , the probability of accumulating DNA errors seems to be much higher in BCR/ABL-positive cells compared with non-transformed cells, because more DNA damage occurs and, while overall repair capability is enhanced, the fidelity of repair mechanisms is compromised. A mutator phenotype may be essential for tumor cells to grow in various organs under diverse conditions and to resist anti-tumor treatments.
This work shows that BCR/ABL elevates the level of ROS resulting in numerous DSBs during genome duplication and division (S and G2/M phase). Unfortunately, the oncogene promotes unfaithful mechanisms of DSBs repair. We hypothesize that elevated levels of DSBs combined with unfaithful repair mechanisms may contribute to genomic instability and malignant progression of the Ph 1 -positive leukemias.
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METHODS

Cells
The murine growth factor-dependent myeloid cell line 32Dcl3 and BCR/ABL-or BCR/ABL[K1172R]-expressing clones 20 have been maintained in the presence of pre-tested optimal concentrations of IL-3 required to maintain their continuous proliferation. Bone marrow mononuclear cells from C57Bl/6 mice (mBMC) (The Jackson Laboratory, Bar Harbor, ME, USA) were infected with BCR/ABL-IRES-GFP or IRES-GFP retroviral particles as described 20 .
GFP+ cells obtained after sorting were cultured for 72h in the presence of pre-tested concentration of IL-3 and used for experiments. Bone marrow cells from CML patients (2 CML chronic phase and 2 CML blast crisis patients) and healthy donors (hBMC) described before 23 were obtained after informed consent. Mononuclear cells were cultured for 72h in the presence of pre-tested recombinant human IL-3 and stem cell factor (SCF) and CD34+ cells were isolated 24 .
Draa-40 25 and BCR/ABL-Draa-40 cells were cultured in DMEM supplemented with 10% FBS.
Inhibitors
Cells were treated with the following compounds: 2µM STI571 (Novartis Pharma AG, Basel, Switzerland), 0.2µM antioxidant pyrrolidine dithiocarbamate (PDTC), 100µM of the nitrone spin traps N-tert-butyl-a-phenylnitrone (PBN) and 5,5-dimethyl-1-pyrroline-N-oxide (DMPO), 2µM
wortmannin and 5mM caffeine (Sigma-Aldrich, St. Louis, MO, USA). STI571, PDTC, PBN, and DMPO were added for 48h, wortmannin and caffeine for 3h.
Comet assay
The comet assay was performed under alkaline conditions as described 26 with modifications 27 .
Comet tail moment was analyzed in 50 images, randomly selected from each sample, in duplicate
For personal use only. on August 31, 2017 . by guest www.bloodjournal.org From experiments (total 100 images/sample); it positively correlates with the level of DNA breakage and alkali labile sites 28 . The value of tail moment in particular sample was taken as an index of DNA damage. Since our measurement system was not calibrated, tail moment was presented in arbitrary units. Results represent mean±SEM (standard deviation of a mean). The data were analyzed using STATISTICA (StatSoft, Tulsa, OK, USA) statistical package. For the enzymatic treatment cells were drained in agarose and covered with an enzyme buffer (control) or the enzyme (1µg/ml of EndoIII or Fpg) in buffer, incubated for 30 min at 37 o C as described 29 , and the comet tail moment was analyzed as described above. The results obtained with a buffer only were subtracted from these obtained with an enzyme (an enzyme treatment usually increased the detection of DNA damage by ~2 -fold.
DNA fragmentation analysis
Genomic DNA was isolated from 3-5x10 6 cells using Dneasy Tissue Kit (Qiagen Inc., Valencia, CA, USA), and 2-3µg, was run (30V for 15 minutes followed by 70V for few hours) in 2.5% agarose gel containing ethidium bromide and photographed.
ROS assay
The levels of intracellular ROS were analyzed in cells growing in the presence of IL-3 using the redox-sensitive fluorochrome 2',7'-dichloro-fluorescin-diacetate 18 . 
HRR assay
Immunofluorescence
Nuclear localization of the indicated proteins was detected by immunofluorescence as previously described 10 . Briefly, cytospins from unsynchronized cells were fixed in PBS + 0.06% Triton X-100 + 4% formamide, washed in PBS + 0.06% Triton X-100, and blocked in washing buffer supplemented with 1% BSA. To perform cell cycle specific analysis cells were washed with PBS, . All graphic adjustments were performed using Adobe Photoshop.
Linker-ligation PCR (LL-PCR) assay
Genomic DNA was purified by DNeasy Tissue Kit (Qiagen, Inc., Valencia, CA, USA). The protocol for LL-PCR to detect broken-ended double-stranded DNA was described by Schlissel et al. 33 and followed with modifications. Briefly, the two oligomers BW-1 (GCGGTGACCCGGGAGATCTGAATTC) and BW-2 (GAATTCAGATC) were annealed to (2 x 20 cycles) the products were detected by Southern analysis using -dCTP labeled DR-GFP probe (NarI-HpaI fragment of the DR-GFP gene) and -ATP labeled Na + /K + ATPase-specific probe (GGCCTACGAGCAAGCTGAG oligomer), respectively.
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RESULTS
BCR/ABL elevates the levels of ROS to induce DSBs.
A comet assay indicated that the presence of BCR/ABL kinase increased the level of DNA damage (strand breaks and abasic sites) on average by ~2.5-fold. Inhibition of the kinase by 48h incubation with 2µM STI571 34 or ROS by 48h incubation with the antioxidants: 0.2µM PDTC 
BCR/ABL stimulates HRR and NHEJ to facilitate the repair of ROS-dependent DSBs.
Since the majority of cells containing DSBs are in S and G2/M cell cycle phases, DSBs could be repaired by the two competing machineries: HRR and/or NHEJ [42] [43] [44] . The efficiency of HRR and NHEJ in BCR/ABL-positive and negative cells were examined using the specific tests. overhangs was used as the substrate to assess the activity of NHEJ, which generates the products containing multimers of plasmid 30, 45 . The substrate was added to cell lysates from BCR/ABL kinase activity was responsible for more than 5-fold increase of NHEJ activity; inactivation of the kinase by point-mutation (K1172R) reduced NHEJ by 2-fold ( Figure 3B ).
HRR and NHEJ reaction sites in the nuclei could be potentially visualized by doubleimmunofluorescence detecting co-localization of -H2AX foci with RAD51 or Ku70, respectively 46 . As shown in Figure 3C about 50% of DSBs marked as -H2AX foci co-localize with RAD51 in parental and BCR/ABL-positive 32Dcl3 cells; similarly about 50% of the -H2AX foci co-localize with Ku70. This suggests that HRR and NHEJ are equally important for the repair of ROS-mediated "spontaneous" DSBs in BCR/ABL cells.
Parental cells treated for 48 h with 100 µM buthionine-sulfoximine (BSO), which inhibits -glutamyl-cysteine synthetase, thus increasing ROS by depleting glutathione pools 47 , displayed enhancement of ROS (data not shown) and increased percentage (56±11) of -H2AX-positive cells (see group P in Figure 2A ). However, elevation of ROS-mediated DSBs in parental cells was not associated with enhanced HRR (1.36±0.3% of GFP+ cells) and NHEJ Figure 3A and 3B, respectively). Finally, about 10-20% of BSO-treated cells have been displaying an apoptotic signature (sub-diploid amount of DNA) after 72h of incubation. These effects were reversed by the anti-oxidant PDTC (data not shown), implicating ROS-dependence.
BCR/ABL promotes mutagenic repair of DSBs
Parental and BCR/ABL-Draa-40 cells were transfected with I-SceI expression plasmid to inflict a DSB in the reporter DR-GFP cassette. The primers spanning a fragment of the DR-GFP cassette containing the DSB site were used 72h later to amplify the repair products by PCR, which were then analyzed by Southern assay and sequenced to determine the frequency and fidelity of a repair mechanism ( Figure 4A ). The sequences with restored BcgI restriction site are considered HRR products; these without BcgI and I-SceI sites are identified as NHEJ products, and these with preserved I-SceI site are considered the replication products (DSB and repair did not occur).
A combined PCR-Southern analysis revealed that HRR and NHEJ consist of ~40% and 60% of DSBs repair products, respectively, and that BCR/ABL does not significantly change this proportion ( Figure 4A , % of repair events), although it enhances both HRR and NHEJ activity ( Figure 3A and 3B) . HRR products obtained from parental cells were repaired faithfully (no mutations found), whereas the products from BCR/ABL-positive cells contained mutations (overall mutation rate: 6 x 10 , which can be detected experimentally as -H2AX foci 65 . We hypothesize that ROS-mediated oxidative DNA lesions in BCR/ABL cells produce numerous DNA repair intermediates, which do not induce the G 1 /S checkpoint in BCR/ABL cells 5, 66 , resulting in DSBs at the replication forks. This speculation is supported by the finding that BCR/ABL cells containing numerous -H2AX foci (marker of DSBs) were detected almost exclusively in S and G2/M phase, but not in G0/G1 phase. This agrees with the previous observation that G 1 cell cycle phase arrest prevented ROS-induced DNA strand breaks 67 . We were able to detect also a few cells with -H2AX foci in G 1 phase, in agreement with the other report that ROS caused DSBs in serum starved G 1 phase fibroblasts 68 .
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We suggest that ROS-dependent DSBs present in BCR/ABL cells occurred in the regions containing multiple, 5-9bp long stretches of G/C. This supports a report that oxidative damage was predominantly detected in G/C-rich sequences 69 . Thus, it is tempting to speculate that the attempts to repair an extensive clustered oxidative damage in BCR/ABL cells may generate DNA lesions, which pose a serious obstacle for replication forks and result in DSBs.
Lower levels of ROS in normal cells may cause limited DNA damage resulting in fewer DSBs, as suggested by detection of less -H2AX foci. Interestingly, LL-PCR did not detect DSBs in parental cells, which may simply reflect a limited sensitivity of the assay, or formation of -H2AX foci on the lesions different than DSBs. -H2AX foci may be detected also on singlestranded DNA at arrested replication fork 70 . We speculate that less abundant oxidative damage in parental and PDTC-treated BCR/ABL cells may cause stalling of a replication fork, which could be resolved by fork regression followed by reverse branch migration, without generation . We show here that the majority of ROS-mediated DSBs occur in S and G2/M cell cycle phases, when both mechanisms are active and competing for a DSB substrate [42] [43] [44] . This work supports previous reports that BCR/ABL stimulated HRR 20 and NHEJ 52, 53 reactions. Moreover, RAD51
and Ku70 co-localize with -H2AX foci (DSBs marker) with the same relative frequency,
suggesting that HRR and NHEJ have an equal opportunity to be employed. Genetic analysis of the DSB repair products supports this hypothesis; about 40% and 60% of these products were 
